(1)
“SALIVARY INTERLEUKIN-6 AS A BIOMARKER OF COVID-19 SEVERITY.” Aca. Glo. Ind.Res. 2023, 4 (02), 45-52. https://doi.org/10.17605/OSF.IO/24H87.